Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced that with effect from May 31, 2024, Dr. WANG Jingyi has resigned as an executive Director of the Company. The Board announces that with effect from May 31, 2024, Mr. LAI Degui and Mr. WAN Peng have each resigned as a Supervisor of the Supervisory Committee. After the aforementioned resignation of Mr. LAI Degui, at the meeting of the Supervisory Committee convened on May 31, 2024, Ms. LIAO Yihong was elected as the chairperson of the Supervisory Committee.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Equities
6990
CNE1000062J1
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
147.6 HKD | +3.80% | -9.67% | +43.44% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.44% | 4.21B | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- 6990 Stock
- News Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Announces Board and Committee Changes